Towards better treatments and care
As the largest European charitable funder of Parkinson's research, we've invested over £100 million in vital research that has delivered groundbreaking discoveries, new medications and better care. And right now new treatments are within our grasp.
Together, we'll find a cure
We’re a powerful global movement of scientists and supporters, investors and innovators. Driven by people with Parkinson’s every step of the way.
We partner with organisations from around the globe to fast-track promising discoveries. And our pioneering research initiatives, like the Parkinson's Virtual Biotech, are filling the gaps and investing in big ideas to accelerate research and deliver better treatments to the people who need them, faster.
Speeding up the search for a cure
Investing in pioneering research
We're backing the best and brightest minds to unlock the ideas that will lead to new treatments, and one day a cure. Our research projects explore all aspects of Parkinson's, from genetics to gut bacteria, stem cells to sleep.
Accelerating drug discovery
Through the Parkinson's Virtual Biotech, we've plugged a critical funding gap that stops promising projects from progressing. We've backed carefully selected research with the greatest potential to transform life for people with Parkinson’s.
We believe this is the missing link in unlocking the treatments of tomorrow. That’s why we’re investing more in our Virtual Biotech than any other research programme. And with your support, this investment is increasing year on year. The next life changing treatment is within reach, and together we can deliver it.
The Parkinson’s Virtual Biotech
The Parkinson’s Virtual Biotech is a groundbreaking global movement to deliver life-changing new treatments in years not decades.
In just 5 years we’ve revolutionised Parkinson’s drug discovery. And our innovative approach is working. The next treatment is closer than ever.
Changing the future of trials
We believe clinical trials can work better, so we’re bringing the right people together in a global collaboration to make trials faster, cheaper and more likely to succeed. With the Critical Path for Parkinson's, we can improve clinical trials and give new treatments the best chance of success.
Identifying drugs with hidden potential
We're taking the fastest route to better treatments by tracking down drugs already approved and in use for other conditions which have untapped potential for Parkinson's. This is called drug repurposing, and it could make new treatments available for people with Parkinson's much more quickly, easily and cheaply.